NYSE: XPERXperi Inc Stock
$10.33-0.62 (-5.66%)
Updated Feb 3, 2023
XPER Price
$10.33
Fair Value Price
N/A
Market Cap
$434.10M
52 Week Low
$8.15
52 Week High
$19.07
P/E
N/A
P/B
0.58x
P/S
N/A
PEG
N/A
Dividend Yield
0.48%
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.38
Operating Cash Flow
N/A
Beta
1.35
Next Earnings
Feb 22, 2023
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XPER scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XPER is good value based on its book value relative to its share price (0.58x), compared to the US Software - Application industry average (5.33x)
P/B vs Industry Valuation
XPER's short-term assets ($336.30M) exceed its short-term liabilities ($142.23M)
Short-term Liabilities Financials
XPER's short-term assets ($336.30M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 35 more XPER due diligence checks available for Premium users.
Be the first to know about important XPER news, forecast changes, insider trades & much more!
XPER News
Valuation
XPER price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.58x
Industry
5.33x
XPER is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XPER's financial health
Profit margin
Revenue
$121.6M
Net Income
-$400.8M
Profit Margin
-329.5%
Assets to liabilities
Assets
$1.0B
Liabilities
$279.7M
Debt to equity
0.38
XPER's short-term assets ($336.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XPER's short-term assets ($336.30M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XPER's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
XPER vs App Stocks
Xperi Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.